Reading time:2 minutes, 21 seconds
With global demand for autoimmune disease treatment expected to reach $117.7 billion by 2025, it’s clear that aggressive and targeted marketing is needed to generate revenue in this industry, writes a blog post describing Autoimmune Disease Treatment Market Size and Forecast to 2026.
What is an autoimmune disease?
Autoimmune disease is the occurrence of an autoimmune response that causes a body-wide or system-wide attack resulting in organ or tissue damage. This means any attack caused by its own immune system against cells, components, molecules and certain proteins as well as systems such as nerves and sexual function. Many autoimmune diseases can be categorized into two main types: tissue-mediated antibody (TAM) and cell-mediated.
Click on the tab below to benefit from the sample copy of the report
Types of autoimmune diseases
Autoimmune diseases are related to the body’s immune system attacking its own healthy cells and other parts of the body. Autoimmune diseases include over 80 types, but this article will look at 15, including multiple sclerosis, lupus, Crohn’s disease, and rheumatoid arthritis. It was estimated by Grubb in 2015 that the total market size for these autoimmune diseases is $130 billion with a compound annual growth rate of 2.8%.
Epidemiology and demography of autoimmunity
The autoimmune disease treatment market is worth USD 152 billion with significant growth potential in the near future. The increasing prevalence of autoimmunity in developed countries is due to an increase in the number of life-changing chronic diseases such as rheumatoid arthritis, type 1 diabetes, Crohn’s disease and lupus, to name a few. to name a few.
Click on the tab below for the instant purchase of the report with a flat rate discount of $500
Instant Buy Request
Market size, shares and trends
The size of the autoimmune disease treatment market is growing. In 2015, the market size stood at $14.2 billion and it is expected to make a market of around $24.3 billion by 2020 with the increase in prevalence . The bulk will remain with drugs and biologics respectively, but diagnostics, procedures, and devices are also expected to see a considerable increase.
Industry To analyse
Autoimmune disease treatment market size: US$ billion
Autoimmune disease market share: X
Industry forecast by year to 2019
Cumulative revenue in billion US dollars (2019)
Autoimmune diseases, including multiple sclerosis, lupus, rheumatoid arthritis and many others, are the leading cause of chronic disability and cancer worldwide. Demand for autoimmune disease treatment is expected to grow from $12.5 billion in 2016 to $19.53 billion by 2021. APAC accounts for 51% of the market base while North America dominates at 43%.
The autoimmune disease treatment market is expected to reach $52.35 billion by 2020, representing a CAGR of approximately 20.9% from 2016 to 2020.